These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 16238705)

  • 21. [Efficacy and tolerability of topiramate, lamotrigine, and levetiracetam in children with refractory epilepsy].
    Kato T; Nakata M; Ide M; Saito K; Yoshida T; Awaya T; Heike T
    No To Hattatsu; 2015 Sep; 47(5):354-9. PubMed ID: 26502652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term retention rates of lamotrigine, gabapentin, and topiramate in chronic epilepsy.
    Lhatoo SD; Wong IC; Polizzi G; Sander JW
    Epilepsia; 2000 Dec; 41(12):1592-6. PubMed ID: 11114218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New pharmacotherapies for pediatric seizures.
    Pellock JM
    Pediatr Ann; 2004 Jun; 33(6):385-91. PubMed ID: 19449513
    [No Abstract]   [Full Text] [Related]  

  • 24. Antiepileptic drug therapy for adults: when to initiate and how to choose.
    Sirven JI
    Mayo Clin Proc; 2002 Dec; 77(12):1367-75. PubMed ID: 12479527
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Refractory epilepsy: treatment with new antiepileptic drugs.
    Datta PK; Crawford PM
    Seizure; 2000 Jan; 9(1):51-7. PubMed ID: 10667964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The new antiepileptic drugs: scientific review.
    LaRoche SM; Helmers SL
    JAMA; 2004 Feb; 291(5):605-14. PubMed ID: 14762040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of lamotrigine, vigabatrin and gabapentin as add-on therapy in intractable epilepsy of childhood.
    McDonald DG; Najam Y; Keegan MB; Whooley M; Madden D; McMenamin JB
    Seizure; 2005 Mar; 14(2):112-6. PubMed ID: 15694564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical administration of new antiepileptic drugs: an overview of safety and efficacy.
    Chadwick DW; Marson T; Kadir Z
    Epilepsia; 1996; 37 Suppl 6():S17-22. PubMed ID: 8941038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of side effects on long-term retention in three new antiepileptic drugs.
    Bootsma HP; Ricker L; Hekster YA; Hulsman J; Lambrechts D; Majoie M; Schellekens A; de Krom M; Aldenkamp AP
    Seizure; 2009 Jun; 18(5):327-31. PubMed ID: 19110447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiepileptic drugs in the treatment of neuropathic pain.
    Eisenberg E; River Y; Shifrin A; Krivoy N
    Drugs; 2007; 67(9):1265-89. PubMed ID: 17547471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [New antiepileptic drugs: characteristics and clinical applications].
    Ohtsuka Y
    Nihon Rinsho; 2014 May; 72(5):931-8. PubMed ID: 24912297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiepileptic drugs for the elderly: using the old to focus on the new.
    French JA; Chadwick DW
    Neurology; 2005 Jun; 64(11):1834-5. PubMed ID: 15955930
    [No Abstract]   [Full Text] [Related]  

  • 33. Anticonvulsant drugs in primary headaches prophylaxis.
    Frediani F
    Neurol Sci; 2004 Oct; 25 Suppl 3():S161-6. PubMed ID: 15549529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of pharmacokinetic interaction of levetiracetam on carbamazepine, valproic acid, topiramate, and lamotrigine in children with epilepsy.
    Otoul C; De Smedt H; Stockis A
    Epilepsia; 2007 Nov; 48(11):2111-5. PubMed ID: 17651416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retention rate of levetiracetam in children with intractable epilepsy at 1 year.
    Peake D; Mordekar S; Gosalakkal J; Mukhtyar B; Buch S; Crane J; Wheway R; Rittey C; Donnelly J; Whitehouse WP; Philip S
    Seizure; 2007 Mar; 16(2):185-9. PubMed ID: 17258474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The 'number needed to treat' with levetiracetam (LEV): comparison with the other new antiepileptic drugs (AEDs).
    van Rijckevorsel K; Boon PA
    Seizure; 2002 Apr; 11 Suppl A():235-6. PubMed ID: 12185762
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparative effectiveness of antiepileptic drugs in patients with mesial temporal lobe epilepsy with hippocampal sclerosis.
    Androsova G; Krause R; Borghei M; Wassenaar M; Auce P; Avbersek A; Becker F; Berghuis B; Campbell E; Coppola A; Francis B; Wolking S; Cavalleri GL; Craig J; Delanty N; Koeleman BPC; Kunz WS; Lerche H; Marson AG; Sander JW; Sills GJ; Striano P; Zara F; Sisodiya SM; Depondt C;
    Epilepsia; 2017 Oct; 58(10):1734-1741. PubMed ID: 28857179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical comparability of the new antiepileptic drugs in refractory partial epilepsy: a systematic review and meta-analysis.
    Costa J; Fareleira F; Ascenção R; Borges M; Sampaio C; Vaz-Carneiro A
    Epilepsia; 2011 Jul; 52(7):1280-91. PubMed ID: 21729036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An audit of lamotrigine, levetiracetam and topiramate usage for epilepsy in a district general hospital.
    Chappell B; Crawford P
    Seizure; 2005 Sep; 14(6):422-8. PubMed ID: 16087359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emergent complications of the newer anticonvulsants.
    Wade JF; Dang CV; Nelson L; Wasserberger J
    J Emerg Med; 2010 Feb; 38(2):231-7. PubMed ID: 18762404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.